Myers Michael has filed 12 insider transactions across 1 company since October 2023.
Most recent transaction: a grant/award of 318750 shares of Quoin Pharmaceuticals, Ltd. ($QNRX) on February 04, 2026.
Activity breakdown: 7 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | A | Share Option (Right to Buy) | 318750 | $0.00 | 318,750.0000 | 1,584,905,594 | 9999.99% | 0.02% |
| May 29, 2025 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | A | Share Option (Right to Buy) | 42857 | $0.00 | 42,857.0000 | 1,584,905,594 | 9999.99% | 0.00% |
| May 29, 2025 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | A | Share Option (Right to Buy) | 42039 | $0.00 | 42,039.0000 | 1,584,905,594 | 9999.99% | 0.00% |
| Dec. 23, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | P | Series G Warrants (right to buy) | 555556 | $0.00 | 555,556.0000 | 1,584,905,594 | 9999.99% | 0.04% |
| Dec. 23, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | P | Series F Warrants (right to buy) | 555556 | $0.00 | 555,556.0000 | 1,584,905,594 | 9999.99% | 0.04% |
| Dec. 23, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | P | Ordinary Shares | 555556 | $0.45 | 602,808.0000 | 1,584,905,594 | 1175.73% | 0.04% |
| Dec. 9, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | A | Share Option (Right to Buy) | 536603 | $0.00 | 536,603.0000 | 1,584,905,594 | 9999.99% | 0.03% |
| Sept. 4, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | P | Ordinary Shares | 5322 | $0.66 | 15,480.0000 | 1,584,905,594 | 52.39% | 0.00% |
| Sept. 4, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | P | Ordinary Shares | 8200 | $0.75 | 23,680.0000 | 1,584,905,594 | 52.97% | 0.00% |
| Sept. 4, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | P | Ordinary Shares | 23572 | $0.80 | 47,252.0000 | 1,584,905,594 | 99.54% | 0.00% |
| Sept. 3, 2024 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | P | Ordinary Shares | 800 | $0.62 | 10,158.0000 | 1,584,905,594 | 8.55% | 0.00% |
| Oct. 26, 2023 | Quoin Pharmaceuticals, Ltd. | $QNRX | Myers Michael | Chief Executive Officer | A | Share Option (Right to Buy) | 80965 | $0.00 | 80,965.0000 | 1,584,905,594 | 9999.99% | 0.01% |